Laylay, Wenejane C.

HRN: 22-02-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFUROXIME 500MG (TAB)
01/26/2023
01/26/2023
IV
1.5 G
Loading
For CS For NRFS
Waiting Final Action 
01/26/2023
CEFUROXIME 1.5GM (VIAL)
01/26/2023
01/28/2023
IV
1.5 G
Q8x 6 Doses
Sp LTCS For NRFS, MS AF
Waiting Final Action 
01/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/26/2023
01/28/2023
IV
500 G
Q8
Sp Lt Cs MSAF
Waiting Final Action 
01/27/2023
CEFUROXIME 500MG (TAB)
01/27/2023
02/02/2023
ORAL
500mg
BID
Thickly MSAF
Waiting Final Action 
01/27/2023
METRONIDAZOLE 500MG (TAB)
01/27/2023
02/02/2023
ORAL
500mg
Tid
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: